Raia Drogasil (BSP:RADL3) YoY EBITDA Growth : 6.56% (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Raia Drogasil's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 6.56%.

Raia Drogasil's EBITDA per Share for the three months ended in Dec. 2023 was R$0.28.

Raia Drogasil YoY EBITDA Growth Historical Data

The historical data trend for Raia Drogasil's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil YoY EBITDA Growth Chart

Raia Drogasil Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

92.31

-2.37

26.42

-3.77

9.69

Raia Drogasil Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-26.42	24.93	2.20	10.55	6.56

Raia Drogasil YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Raia Drogasil's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(1.596	-	1.455)	/	\| 1.455 \|
=	9.69 %

Raia Drogasil's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.276	-	0.259)	/	\| 0.259 \|
=	6.56 %

Raia Drogasil YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Raia Drogasil (BSP:RADL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

RADLY:USA

Address

Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000

Website

https://ri.rd.com.br

Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines